510(k) · Cleared
ClearedTrue Dilatation Balloon Valvuloplasty Catheter
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
C.R. Bard, Inc. · OZT Balloon Aortic Valvuloplasty
Cleared on Jun 17, 2015 as substantially equivalent to K133569 (Bard Peripheral Vascular, Inc., 2013) after a 93-day review. Its family tree reaches back 2 generations to 2012.
- Decided
- Jun 17, 2015
- Review
- 93 days
- Class
- Class II
- Product code
- OZT
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 2 generations to K121083 (2012). No later device cites it as a predicate yet.
- Root · 2 generations backK121083 True Dilatation Percutaneous Transluminal Valvuloplasty Catheter…Loma Vista Medical · 2012 · Recalled
- 1 generation backK133569 True Dilatation Balloon Valvuloplasty Catheter, 20MM X 4.5 CM, 22MM…Bard Peripheral Vascular, Inc. · 2013
- This deviceK150667 True Dilatation Balloon Valvuloplasty CatheterC.R. Bard, Inc. · 2015
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K121083 | True Dilatation Percutaneous Transluminal Valvuloplasty Catheter, 20MM X… | Loma Vista Medical | 2012 | 1 |
| −1 | K133569 | True Dilatation Balloon Valvuloplasty Catheter, 20MM X 4.5 CM, 22MM X 4.5CM… | Bard Peripheral Vascular, Inc. | 2013 | — |
| 0 (this device) | K150667 | True Dilatation Balloon Valvuloplasty Catheter | C.R. Bard, Inc. | 2015 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OZT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new OZT device
- #1 K253855 KardiaPSI Balloon Catheterscore 11.3 · 1 generation · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K133569 | True Dilatation Balloon Valvuloplasty Catheter, 20MM X 4.5 CM, 22MM X 4.5CM, 24 MM X…Summary page 4…Classification: Class II Classification Panel: Cardiovascular Predicate Device: True™ Dilatation Balloon Valvuloplasty Catheter (K133569; cleared December 20, 2013) Summary of Change: The modifications from the predicate device, the True™ Dilatation Balloo… | 2013 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 3 years and passes through 3 companies; a new generation was cleared every 1.5 years on median.
- 1 of the 2 ancestors has a recall of any class.
- 2 other devices also cite its predicate K133569.
How does its category compare?
All OZT devicesOZT Balloon Aortic Valvuloplasty: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.
FDA decisions per year · OZT
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · OZT
115in 2015
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · OZT
No recall names OZT since 2007.
Adverse event reports per year · OZT
34in 2025
MAUDE reports naming product code OZT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 3 | — | 0 | 0 |
| 2013 | 3 | 80 | 0 | 29 |
| 2014 | 4 | 79 | 0 | 17 |
| 2015 | 4 | 115 | 0 | 16 |
| 2016 | 1 | — | 0 | 9 |
| 2017 | 1 | — | 0 | 38 |
| 2018 | 0 | — | 0 | 31 |
| 2019 | 0 | — | 0 | 10 |
| 2020 | 0 | — | 0 | 11 |
| 2021 | 0 | — | 0 | 18 |
| 2022 | 1 | — | 0 | 33 |
| 2023 | 1 | — | 0 | 47 |
| 2024 | 1 | — | 0 | 38 |
| 2025 | 1 | — | 0 | 34 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
The True™ Dilatation Balloon Valvuloplasty Catheter is indicated for balloon aortic valvuloplasty.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K150667 · printed Nov 6, 2026
Cite this page
510(k) Report. “K150667: True Dilatation Balloon Valvuloplasty Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K150667
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026